Skip to article
Astra

Nephrology

Nephritic Syndrome

Nephritic syndrome requires rapid separation of infection-related immune-complex disease from ANCA-associated, anti-GBM, complement-mediated, and monoclonal processes, with urgent biopsy and serologies when kidney function declines or pulmonary hemorrhage is suspected.

Clinical question: How should clinicians rapidly evaluate and direct initial management of nephritic syndrome with hematuria, proteinuria, and declining kidney function?

First hours

Identify rapidly progressive and pulmonary-renal presentations

Escalate according to the pace of kidney injury and evidence of life-threatening extrarenal disease.

Treat nephritic syndrome with rising creatinine, oliguria, active urine sediment, or suspected crescentic glomerulonephritis as a nephrologic emergency. Rapidly progressive glomerulonephritis (RPGN) is most often associated with anti-GBM disease, ANCA-associated vasculitis (AAV), or immune-complex glomerulonephritis. ScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirectPubMedEvidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014 - PMC

When acute kidney injury coexists with alveolar hemorrhage or otherwise unexplained simultaneous pulmonary and kidney injury, use a pulmonary-renal framework: obtain anti-GBM antibody and MPO- and PR3-ANCA testing urgently, assess for diffuse alveolar hemorrhage, and arrange nephrology-directed tissue diagnosis. A positive anti-GBM antibody result warrants urgent plasma exchange without waiting for biopsy. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...

Do not use a positive ANCA result as a substitute for clinicopathologic diagnosis. ANCA supports AAV in the appropriate syndrome, but anti-GBM/ANCA double positivity occurs, and renal pathology can demonstrate overlapping immune-complex and necrotizing lesions. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitisasn-onlineAmerican Society of Nephrology | Kidney Week - Abstract Details (2019)WileyANCA‐Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab - Sharmeen - 2018 - Case Reports in Rheumatology - Wiley Online Library

Urgent clinical patterns that alter initial testing and intervention. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...ScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirect
PresentationImmediate diagnostic priorityAction changed by the result
AKI plus diffuse alveolar hemorrhage or pulmonary infiltratesAnti-GBM antibody; MPO-ANCA and PR3-ANCA; urgent kidney-biopsy planning. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...Positive anti-GBM antibody supports anti-GBM disease and urgent plasma exchange before biopsy confirmation. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...
Rapid creatinine rise with active sedimentUrine microscopy, ANCA, anti-GBM antibody, and kidney biopsy when feasible. BMJAssessment and management of non-visible haematuria in primary ...Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisDistinguish pauci-immune, anti-GBM, and immune-complex crescentic disease before definitive immunosuppressive strategy. ScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirectKidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis
AKI after or during bacteremia, abscess, endocarditis, or other infectionBlood cultures or source-specific microbiology plus kidney biopsy when diagnosis remains uncertain. acpjournalsBartonella henselae Infective Pulmonic Valve Endocarditis ...community asn-onlineCommunity Minded - ASN CommunityPrioritize infection control; avoid reflex immunosuppression for infection-related glomerulonephritis. community asn-onlineCommunity Minded - ASN Community

Diagnostic core

Confirm glomerular injury and obtain an etiologic serologic panel

Use urine findings, kidney-function trajectory, complement patterns, targeted serologies, and biopsy rather than a syndrome label alone.

Confirm that hematuria is glomerular before pursuing a broad vasculitis workup. Red cell casts are virtually pathognomonic for glomerular pathology. Acanthocytes are associated with glomerular disease, whereas the broader category of dysmorphic erythrocytes is less specific and requires fresh urine examined by experienced personnel. BMJAssessment and management of non-visible haematuria in primary ...

Obtain serum creatinine, quantitative proteinuria, urinalysis with microscopy, and targeted serologies that separate anti-GBM disease, AAV, lupus nephritis, infection-related disease, cryoglobulinemic disease, complement-mediated disease, and monoclonal immunoglobulin-associated glomerulonephritis. The central etiologic categories are immune-complex GN, pauci-immune/ANCA-associated GN, anti-GBM GN, C3 glomerulopathy, and monoclonal immunoglobulin-associated GN. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritisKidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis

Use the clinical setting to prioritize testing. Acute nephritic or RPGN presentations are particularly associated with post-infectious GN, AAV, and anti-GBM disease; episodic flares are characteristic of IgA nephropathy and C3 glomerulopathy. ScienceDirectAcute glomerulonephritis - ScienceDirect In a patient with concurrent infection and glomerular injury, determine whether infection is active before initiating immunosuppression, particularly with Staphylococcus-associated IgA-dominant infection-related GN. community asn-onlineCommunity Minded - ASN Community

Etiologic framework for biopsy-directed interpretation of nephritic syndrome. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritisScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirect
Etiologic branchKey clinical discriminatorExpected pathology categoryImmediate next step
Anti-GBM diseaseRPGN with positive anti-GBM antibody; may present as pulmonary-renal syndrome. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...Anti-GBM GN; anti-GBM disease is one of the three major immunopathologic RPGN categories. ScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirectBegin urgent plasma exchange after positive anti-GBM serology; obtain biopsy without delaying treatment. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...
ANCA-associated vasculitisMPO- or PR3-ANCA supports AAV in a compatible renal or pulmonary-renal syndrome. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisPauci-immune necrotizing/crescentic GN. ScienceDirectAcute glomerulonephritisScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirectObtain biopsy for confirmation and prognostic classification; use glucocorticoids plus cyclophosphamide or rituximab as standard treatment options for RPGN. ScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirectKidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis
Immune-complex GNInfection, lupus, IgA nephropathy, or cryoglobulinemic context. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritisImmune deposits on immunofluorescence; diffuse proliferative injury may occur with infection, lupus, or cryoglobulinemia. ScienceDirectAcute glomerulonephritis - ScienceDirectIdentify and treat the underlying infection or systemic immune disorder; use biopsy to distinguish overlapping processes. ScienceDirectAcute glomerulonephritis - ScienceDirectcommunity asn-onlineCommunity Minded - ASN Community
C3 glomerulopathyFlare-prone glomerular disease; alternative-complement pathway abnormalities can produce an MPGN pattern. ScienceDirectAcute glomerulonephritis - ScienceDirectComplement-dominant injury pattern. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritisUse biopsy and complement-focused etiologic assessment rather than assigning disease solely from an MPGN light-microscopy pattern. ScienceDirectAcute glomerulonephritis - ScienceDirect
Monoclonal immunoglobulin-associated GNMonoclonal immunoglobulin-associated disease is a distinct etiologic category. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritisMonoclonal immunoglobulin-associated deposition pattern. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritisPursue clone-directed diagnostic evaluation after pathologic identification. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritis

When to biopsy

Arrange kidney biopsy urgently when there is rapidly progressive kidney dysfunction, suspected crescentic GN, an uncertain immune mechanism, or discordance between the clinical syndrome and serology. Immunofluorescence generally permits etiologic classification, and kidney histology provides prognostic information in ANCA-associated GN. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritisKidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis

Do not delay urgent anti-GBM-directed plasma exchange for biopsy in a patient with a positive anti-GBM antibody and compatible RPGN or pulmonary-renal presentation. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...

Etiology

Use immunofluorescence and clinical context to direct cause-specific treatment

A proliferative or crescentic pattern is not itself a diagnosis.

Interpret light microscopy together with immunofluorescence and electron microscopy when available. The same histologic pattern can arise from different mechanisms: an MPGN pattern may reflect hepatitis C-associated immune-complex disease or alternative-complement pathway abnormalities, while diffuse proliferative GN can result from infection, lupus, or cryoglobulinemia. ScienceDirectAcute glomerulonephritis - ScienceDirect Therefore, select treatment based on the causal category rather than the descriptive biopsy pattern alone. ScienceDirectAcute glomerulonephritis

For pauci-immune/ANCA-associated RPGN, glucocorticoids combined with cyclophosphamide or rituximab are standard treatment options; plasma exchange has a more selective role than in anti-GBM disease. ScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirect Biopsy remains valuable even with a positive ANCA because kidney histology predicts long-term kidney-failure risk and supports histopathologic prognostic classification. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis

For anti-GBM disease, combine urgent plasma exchange with corticosteroids and immunosuppressive therapy in the RPGN presentation. PubMedEvidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014 - PMC Check ANCA concurrently because a meaningful subset of anti-GBM nephritis cases are double positive, which may affect diagnostic interpretation and longer-term disease assessment. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitisasn-onlineAmerican Society of Nephrology | Kidney Week - Abstract Details (2019)

For infection-related GN, control the infection and confirm the diagnosis pathologically when the renal course is severe or atypical. In Staphylococcus bacteremia with IgA-dominant infection-related GN, corticosteroid use after antimicrobial response remains debated; immunosuppression can add serious infection risk. community asn-onlineCommunity Minded - ASN Community

Treatment priorities by urgent nephritic syndrome branch. ScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirectcommunity asn-onlineCommunity Minded - ASN CommunityKidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...PubMedEvidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014 - PMC
BranchTreatment priorityImportant exception or tradeoff
Anti-GBM diseaseUrgent plasma exchange after positive anti-GBM antibody, plus corticosteroids and immunosuppressive therapy. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...PubMedEvidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014 - PMCDo not wait for biopsy to begin plasma exchange when serology and clinical syndrome are compatible. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisKidney InternationalKDIGO 2021 Clinical Practice Guideline for the ...
ANCA-associated RPGNGlucocorticoids with cyclophosphamide or rituximab; consider plasma exchange selectively. ScienceDirectRapidly Progressive Glomerulonephritis - ScienceDirectUse kidney biopsy for prognostic assessment even when ANCA is positive. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis
Infection-related GNEradicate the infection and obtain source control when indicated. community asn-onlineCommunity Minded - ASN CommunitySteroids in Staphylococcus-associated IgA-dominant GN are controversial and may increase infection-related harm. community asn-onlineCommunity Minded - ASN Community
Immune-complex, complement-mediated, or monoclonal diseaseDirect therapy to the identified systemic immune, complement, infectious, or monoclonal driver. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritisDo not treat an MPGN or proliferative pattern as a uniform disease entity. ScienceDirectAcute glomerulonephritis - ScienceDirectScienceDirectAcute glomerulonephritis

Follow-through

Monitor kidney trajectory, pulmonary disease, treatment toxicity, and diagnostic revision

The response trajectory should confirm or challenge the initial etiologic assignment.

Track serial serum creatinine, urine output, urine sediment, and quantitative proteinuria during acute management. Persistent or worsening kidney injury despite appropriate infection control, anti-GBM-directed therapy, or AAV induction should prompt review of biopsy adequacy, immunofluorescence findings, competing acute tubular injury, obstructive disease, medication exposures, and a second glomerular process. Mixed immune-complex and pauci-immune lesions are documented in lupus nephritis and IgA nephropathy. WileyANCA‐Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab - Sharmeen - 2018 - Case Reports in Rheumatology - Wiley Online Libraryasn-onlineAmerican Society of Nephrology | Kidney Week - Abstract Details (2024)

In AAV, use kidney histology as part of longer-term prognostic counseling because histopathologic classifications based on glomerular lesions predict risk of kidney failure. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis Clinical remission assessment must distinguish active vasculitic GN from chronic scarring, since escalating immunosuppression for irreversible damage increases toxicity without restoring renal function. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis

For hematuria without kidney-function decline or significant proteinuria, avoid assuming all non-visible hematuria is nephritic syndrome. In patients younger than 40 years with asymptomatic non-visible hematuria, renal causes such as IgA nephropathy and thin basement membrane disease are more likely than urologic disease, and urologic referral is not routinely necessary solely on that basis. BMJAssessment and management of non-visible haematuria in primary ...

Follow-up findings that should change the working diagnosis or management. BMJAssessment and management of non-visible haematuria in primary ...WileyANCA‐Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab - Sharmeen - 2018 - Case Reports in Rheumatology - Wiley Online Librarycommunity asn-onlineCommunity Minded - ASN CommunityKidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitisasn-onlineAmerican Society of Nephrology | Kidney Week - Abstract Details (2024)
Follow-up findingInterpretationNext action
Creatinine continues to rise despite initial therapyConsider uncontrolled active GN, inadequate infection control, acute tubular injury, or mixed pathology. WileyANCA‐Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab - Sharmeen - 2018 - Case Reports in Rheumatology - Wiley Online Librarycommunity asn-onlineCommunity Minded - ASN Communityasn-onlineAmerican Society of Nephrology | Kidney Week - Abstract Details (2024)Review biopsy and serologies; reassess infectious source and treatment strategy. WileyANCA‐Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab - Sharmeen - 2018 - Case Reports in Rheumatology - Wiley Online Librarycommunity asn-onlineCommunity Minded - ASN CommunityKidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis
New hypoxemia or pulmonary infiltratesPossible diffuse alveolar hemorrhage in pulmonary-renal syndrome. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitisasn-onlineAmerican Society of Nephrology | Kidney Week - Abstract Details (2024)Urgently reassess anti-GBM and ANCA-mediated disease activity and coordinate pulmonary evaluation. Kidney InternationalKDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis
Persistent hematuria but stable kidney function and no significant proteinuriaMay represent isolated glomerular hematuria rather than active nephritic syndrome. BMJAssessment and management of non-visible haematuria in primary ...Risk-stratify for renal versus urologic evaluation according to age, symptoms, and renal findings. BMJAssessment and management of non-visible haematuria in primary ...

References

  1. Patrick H. Nachman, MD CVwww.fda.gov · www.fda.gov
  2. March 1, 2023 Meeting Briefing Document- Sponsor GSKwww.fda.gov · www.fda.gov
  3. Assessment and management of non-visible haematuria in primary ...www.bmj.com · www.bmj.com
  4. Revolutionizing Autoimmune Kidney Disease Treatment with Chimeric Antigen Receptor-T Cell Therapyspj.science.org · spj.science.org
  5. Differentiation of crescent-forming kidney progenitor cells into podocytes attenuates severe glomerulonephritis in micewww.science.org · www.science.org
  6. Characterizing the Real-World Risks of Kidney Injuries Associated with Chimeric Antigen Receptor T Cell Therapies—Evidence and Safetyspj.science.org · spj.science.org
  7. Bartonella henselae Infective Pulmonic Valve Endocarditis ...www.acpjournals.org · www.acpjournals.org
  8. Acute glomerulonephritis - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  9. Acute glomerulonephritiswww.sciencedirect.com · www.sciencedirect.com
  10. Rapidly Progressive Glomerulonephritis - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  11. Mycophenolate Mofetil in Low Doses Stabilizes and Improves Antineutrophil Cytoplasmic Antibody-associated Vasculitis and Lupus Nephritis - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  12. ANCA‐Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab - Sharmeen - 2018 - Case Reports in Rheumatology - Wiley Online Libraryonlinelibrary.wiley.com · onlinelibrary.wiley.com
  13. Kidney Week 2025 Early Program - Glomerular Diseases: 2025 Updatelearn.asn-online.org · learn.asn-online.org
  14. American Society of Nephrology | Online Store - Shopwww.asn-online.org · www.asn-online.org
  15. Community Minded - ASN Communitycommunity.asn-online.org · community.asn-online.org
  16. Media Library - Clinical Journal of ...www.asn-online.org · www.asn-online.org
  17. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitiswww.kidney-international.org · www.kidney-international.org
  18. KDIGO 2021 Clinical Practice Guideline for the ...www.kidney-international.org · www.kidney-international.org
  19. Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014 - PMCwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  20. American Society of Nephrology | Kidney Week - Abstract Details (2019)www.asn-online.org · www.asn-online.org
  21. American Society of Nephrology | Kidney Week - Abstract Details (2024)www.asn-online.org · www.asn-online.org
  22. Study Details | NCT04662723 | Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy. | ClinicalTrials.govclinicaltrials.gov · clinicaltrials.gov
  23. Study Details | NCT06676384 | Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy? | ClinicalTrials.govclinicaltrials.gov · clinicaltrials.gov
  24. The Canadian Childhood Nephrotic Syndrome Project ( ...cdn.clinicaltrials.gov · cdn.clinicaltrials.gov